by Friese, M.A. et al.
Medical Research Council Human Immunology Unit and Department of Clinical Neurology, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, UK
Medical Research Council Human Immunology Unit and Department of Clinical Neurology, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, UK
These results suggest that ASIC1 blockers could provide neuroprotection in multiple sclerosis.
Nat. Med. 2007; 12:1483-9
